Nilanjan Ghosh, MD, PhD, Levine Cancer Institute, Charlotte, NC, briefly discusses the results of a study evaluating the uptake of genomic testing for chronic lymphocytic leukemia (CLL) in small centers, describing the different tests available, when they should be performed, and how they may impact treatment decisions. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
Explore our dedicated feature on genomic testing in CLL here: http://bit.ly/403y417
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.